Traws Pharma (TRAW) Total Current Liabilities (2012 - 2026)
Traws Pharma (TRAW) posted quarterly Total Current Liabilities of $13.2 million for Q1 2026, up 26.99% year-over-year from $10.4 million in Q1 2025, and up 18.5% quarter-over-quarter from $11.1 million in Q4 2025.
Traws Pharma (TRAW) Total Current Liabilities (2012 - 2026) Analysis & Trends
Traws Pharma (TRAW) has reported Total Current Liabilities for 15 consecutive years, with $13.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Current Liabilities rose 26.99% year-over-year to $13.2 million; the TTM figure through Mar 2026 stood at $13.2 million (up 26.99% YoY), while the FY2025 annual figure was $11.1 million, down 3.36% from the prior year.
- Total Current Liabilities grew to $13.2 million in Q1 2026 per TRAW's latest filing, from $11.1 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $13.2 million in Q1 2026 and bottomed at $5.9 million in Q1 2022.
- Historically, Total Current Liabilities has averaged $9.0 million across 5 years, with a median of $9.2 million in 2023.
- Annual changes were most pronounced in 2023 — Total Current Liabilities surged 55.08% — and 2025, when it dropped 25.81%.
- Traws Pharma's Total Current Liabilities stood at $8.0 million in 2022, then grew by 14.59% to $9.2 million in 2023, then rose by 25.09% to $11.5 million in 2024, then dropped by 3.36% to $11.1 million in 2025, then climbed by 18.5% to $13.2 million in 2026.
- Business Quant data shows TRAW's Total Current Liabilities at $13.2 million in Q1 2026, $11.1 million in Q4 2025, and $7.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.58 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 2.53 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 2.12 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.51 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 438.74 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 630.93 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 2.49 Bn |
| 10 | Traws Pharma | 5.60 Mn | 588,417.40 | - | 9.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.21 Mn |
| Dec 31, 2025 | 11.15 Mn |
| Sep 30, 2025 | 7.89 Mn |
| Jun 30, 2025 | 7.35 Mn |
| Mar 31, 2025 | 10.40 Mn |
| Dec 31, 2024 | 11.53 Mn |
| Sep 30, 2024 | 8.35 Mn |
| Jun 30, 2024 | 9.91 Mn |
| Mar 31, 2024 | 9.42 Mn |
| Dec 31, 2023 | 9.22 Mn |
| Sep 30, 2023 | 9.67 Mn |
| Jun 30, 2023 | 8.67 Mn |
| Mar 31, 2023 | 9.22 Mn |
| Dec 31, 2022 | 8.05 Mn |
| Sep 30, 2022 | 7.34 Mn |
| Jun 30, 2022 | 6.46 Mn |
| Mar 31, 2022 | 5.95 Mn |
| Dec 31, 2021 | 6.12 Mn |
| Sep 30, 2021 | 7.03 Mn |
| Jun 30, 2021 | 7.50 Mn |